Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Revelation Biosciences And 2 Other Penny Stocks Insiders Are Buying

Published 20/04/2023, 12:38
© Reuters. Revelation Biosciences And 2 Other Penny Stocks Insiders Are Buying

Benzinga - The Dow Jones closed lower by around 80 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Revelation Biosciences

  • The Trade: Revelation Biosciences, Inc. (NASDAQ: REVB) Director George F Tidmarsh acquired a total 51,500 shares an average price of $1.16. To acquire these shares, it cost around $59.74 thousand.
  • What’s Happening: Revelation Biosciences posted a wider-than-expected Q4 loss.
  • What Revelation Biosciences Does: Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease.

Earth Science Tech

  • The Trade: Earth Science Tech, Inc. (OTC: ETST) CEO Giorgio R Saumat acquired a total of 9,709 shares at an average price of $0.04. The insider spent around $388.74 to buy those shares.
  • What’s Happening: Earth Science Tech recently said that its wholly owned subsidiary, RxCompoundStore.com, LLC, has received approval to fulfill in the States of Nevada, Delaware, and Pennsylvania.
  • What Earth Science Tech Does: Earth Science Tech Inc is a biotechnology company. The company is engaged in research and development for hemp cannabinoid (CBD), nutraceutical, pharmaceutical, and medical device.

flooidCX

  • The Trade: flooidCX Corp. (OTC: FLCX) CEO Dennis M Danzik acquired a total of 1,500 shares at an average price of $3.45. To acquire these shares, it cost around $5.17 thousand.
  • What’s Happening: The company’s shares jumped 330% over the past month.
  • What flooidCX Does: FlooidCX Corp acts as an online complaint resolution platform for consumers and businesses. The company offers unified communications and collaboration in online CRM solutions - GripeVine and Resolution1.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.